🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Nu Skin Enterprises, Inc. NUS R2K

Consumer Defensive · Household & Personal Products · United States
https://www.nuskin.com

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

READ MORE ›
$5.79
-31.01% 1Y

Market & Price

Market Cap
$281.11M
Current Price
$5.79
High / Low (52W)
$12.55 / $5.64
Beta
1.02

Valuation

Stock P/E
5.36
Industry PE
18.88
Forward P/E
4.39
PEG Ratio
0.78
Book Value
$16.34
Price to Book
0.35
P/S
0.20
EV/EBITDA
2.91
Dividend Yield
4.15%

Profitability & Returns

ROCE
18.41%
ROE
7.04%
ROA
3.68%
Profit Margin
3.78%
Op Margin
1.83%
EPS (Latest Qtr)
$0.04
EPS (TTM)
$1.08

Balance Sheet & Liquidity

Debt/Equity
0.38
Quick Ratio
0.95
Current Ratio
2.04
Debt
$303.25M
Total Assets
$1.41B
Current Assets
$547.70M
Working Capital
$283.96M

Ownership

Promoter Holding
3.11%
Chg in Prom Hold
-
FII / Inst Holding
76.61%
Chg in FII Hold
-0.12%

Financial Snapshot

Enterprise Value
$383.95M
Total Revenue (TTM)
$1.44B
EBITDA
$131.93M
Free Cash Flow
$61.60M
Operating Cash Flow
$75.98M
Shares Outstanding
48.55M
Gross Margin
69.31%
Payout Ratio
22.22%

Growth (CAGR)

Revenue 5Y
-12.61%
Profit 5Y
15.20%
Revenue (YoY)
-12.00%
Earnings (YoY)
-98.20%

PROS

  • Profit CAGR of 15.2% over 5 years.
  • Attractive dividend yield of 4.15%.
  • Generates positive free cash flow.

CONS

  • Revenue declined at -12.6% CAGR over 5 years.
  • Trading 53.9% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NUS Nu Skin Enterprises, Inc. R2K 5.79 5.36 $281.11M 4.15% 18.41% 7.04% -12.61% 15.20%
2 WMT Walmart Inc. SPX 115.75 40.76 $922.64B 0.86% 18.21% 24.13% 5.27% 23.30%
3 COST Costco Wholesale Corporation NDXSPX 956.32 49.76 $424.27B 0.61% 27.44% 29.65% 6.64% 11.49%
4 KO The Coca-Cola Company SPX 79.01 24.85 $339.94B 2.68% 21.13% 43.37% 3.69% 11.16%
5 PG The Procter & Gamble Company SPX 143.56 21.02 $334.29B 2.97% 23.63% 31.11% 1.67% 2.71%
6 PM Philip Morris International Inc. SPX 177.38 24.98 $276.46B 3.31% 35.35% - 8.57% 7.84%
7 PEP PepsiCo, Inc. NDXSPX 144.19 22.64 $197.10B 4.11% 15.23% 43.88% 2.83% -2.57%
8 MO Altria Group, Inc. SPX 69.58 14.53 $116.19B 6.09% 40.85% - -0.89% 6.42%
9 MNST Monster Beverage Corporation NDXSPX 88.08 42.55 $86.14B - 28.33% 26.65% 9.54% 16.94%
Ad space

Quarterly Results

Figures in USD.

Metric Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------499.10M550.10M563.70M616.22M704.19M675.31M623.62M623.50M589.93M518.03M612.37M703.35M677.03M704.05M641.15M604.90M560.62M537.80M481.46M500.26M498.77M417.31M439.08M430.14M364.49M386.14M364.21M370.32M320.61M
Cost of Revenue -----------------------------------117.53M120.41M107.49M108.34M106.14M
Gross Profit 564.40M494.00M529.50M503.10M438.28M449.95M418.55M450.80M333.96M472.27M478.30M387.83M428.58M442.87M469.94M535.64M517.86M476.96M469.47M449.77M392.24M458.26M519.97M506.46M532.08M482.25M443.40M412.51M364.31M347.87M364.71M292.27M294.06M307.18M301.46M246.96M265.73M256.72M261.98M214.46M
Operating Expenses -----------------------------------231.75M234.95M235.08M238.74M208.60M
Operating Income 101.20M54.70M105.00M91.30M68.65M71.80M42.54M61.70M8.15M79.80M82.37M46.26M64.74M64.36M58.99M82.76M80.67M68.65M74.20M69.89M36.56M58.07M74.23M62.91M85.38M65.38M52.15M51.53M-20.28M16.06M42.51M-26.36M8.82M-125.56M18.23M15.21M30.78M21.64M23.24M5.87M
EBITDA -----------------------------------152.09M42.99M32.23M35.10M19.19M
Interest Expense -----------------------------------3.28M2.53M4.14M3.99M4.25M
Pretax Income -----------------------------------134.60M27.41M15.99M18.19M2.60M
Tax Provision -----------------------------------27.09M6.29M-1.08M3.70M763.00K
Net Income 54.90M19.50M68.30M46.50M36.28M44.66M16.27M35.80M3.32M44.71M56.87M27.49M42.04M41.67M35.54M50.96M53.15M43.00M46.35M44.09M19.73M41.85M56.31M47.43M59.34M49.73M38.72M34.24M-25.39M11.38M26.89M-36.95M-533.00K-118.26M8.30M107.52M21.12M17.08M14.49M1.84M
Diluted EPS 0.900.321.120.770.600.750.280.620.060.790.980.510.770.760.640.900.940.770.830.790.360.811.080.911.150.970.760.67-0.510.230.54-0.74-0.01-2.380.172.140.430.340.290.04

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --------2.21B2.28B2.68B2.42B2.58B2.70B2.23B1.97B1.73B1.49B
Cost of Revenue --------------630.91M611.85M550.23M453.76M
Gross Profit 1.02B1.09B1.26B1.40B1.78B2.67B2.09B1.76B1.71B1.78B2.04B1.84B1.92B2.02B1.59B1.36B1.18B1.03B
Operating Expenses --------------1.44B1.29B1.13B940.52M
Operating Income 125.43M147.71M217.06M233.74M340.84M554.11M352.19M244.70M231.10M274.48M240.86M267.43M257.56M233.99M159.34M68.06M50.77M90.88M
EBITDA --------------174.97M123.06M-78.83M262.41M
Interest Expense --------------13.49M25.56M26.41M13.95M
Pretax Income --------------88.97M26.58M-175.05M196.20M
Tax Provision ---------------15.81M17.98M-28.46M35.99M
Net Income 65.35M89.84M136.05M153.33M221.65M364.89M189.18M133.05M143.09M129.44M121.89M173.55M191.35M147.27M104.78M8.60M-146.59M160.20M
Diluted EPS 1.021.402.112.383.525.943.112.252.552.362.163.103.632.862.070.17-2.953.18
R&D Expense -10.40M12.40M13.60M14.90M18.00M18.90M20.10M24.30M22.00M23.00M30.10M23.30M27.20M23.30M22.60M13.00M10.80M

Compounded Sales Growth

5 Years:-12.61%
1 Year:-12.00%

Compounded Profit Growth

5 Years:15.20%
1 Year:-98.20%

Stock Price Performance

1 Year:-31.01%
6 Months:-41.47%
3 Months:-31.03%
1 Month:-18.09%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --748.45M892.22M990.96M1.12B1.82B1.61B1.51B1.47B1.59B1.69B1.77B1.96B-1.82B1.81B1.47B1.41B
Current Assets ---------------759.87M701.87M538.60M547.70M
Cash & Equivalents 87.33M114.59M158.04M230.34M272.97M320.02M525.15M288.42M289.35M357.25M426.40M386.91M335.63M402.68M-264.73M256.06M186.88M238.63M
Inventory ---------------346.18M279.98M190.24M178.64M
Receivables ---------------47.36M58.70M50.78M39.54M
Total Liabilities --372.76M420.98M416.72M534.20M962.44M672.00M680.22M809.98M885.28M912.58M893.72M1.06B-923.67M986.66M817.46M600.07M
Current Liabilities --185.21M216.45M241.17M320.10M776.79M418.33M407.60M399.01M447.37M439.65M356.76M542.86M-359.24M328.87M296.61M263.73M
Long Term Debt --121.12M133.01M107.94M154.96M113.85M164.57M181.75M334.17M310.79M361.01M334.46M305.39M-377.47M478.04M363.61M204.19M
Total Debt ---------------520.52M607.33M478.23M306.61M
Total Equity 275.01M316.18M375.69M471.25M574.24M590.61M858.62M942.44M825.62M664.07M704.60M781.87M875.29M894.27M-897.30M821.97M651.46M805.24M
Shares Outstanding ---------------90.60M90.60M90.61M90.60M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 103.31M133.94M187.88M224.31M310.98M530.18M-322.11M275.26M302.56M202.74M177.93M379.14M-108.06M118.64M111.74M80.29M
Investing Cash Flow -10.78M-20.21M-53.78M-71.20M-104.86M-193.70M--60.85M-57.86M-91.96M-108.76M-71.41M-79.43M--67.08M-134.50M-37.96M170.66M
Financing Cash Flow -62.69M-73.01M-69.02M-107.01M-163.89M-120.72M--235.92M-134.71M-159.57M-116.71M-154.79M-245.17M--99.50M10.73M-133.18M-202.40M
Capital Expenditure -16.01M-20.21M-53.78M-41.81M-96.64M-185.10M-101.48M-56.62M-50.22M-60.16M-70.37M-66.07M-63.82M--59.06M-58.49M-41.58M-34.28M
Free Cash Flow 87.30M113.73M134.10M182.51M214.33M345.07M-265.49M225.04M242.40M132.37M111.86M315.32M-49.01M60.15M70.16M46.01M
Net Change in Cash ---------------58.52M-5.13M-59.40M48.54M
Share Buybacks 6.09M21.14M58.52M67.15M201.47M140.87M45.72M164.09M247.21M71.73M69.56M825.00K144.33M80.42M70.05M13.01M020.04M

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --------77.3%78.0%76.3%76.0%74.5%75.0%71.7%68.9%68.2%69.4%
Operating Margin % --------10.5%12.0%9.0%11.0%10.0%8.7%7.2%3.5%2.9%6.1%
Net Margin % --------6.5%5.7%4.5%7.2%7.4%5.5%4.7%0.4%-8.5%10.8%
ROE % 20.7%23.9%28.9%26.7%37.5%42.5%20.1%16.1%21.5%18.4%15.6%19.8%21.4%-11.7%1.0%-22.5%19.9%
ROCE % -26.2%32.1%31.2%42.4%53.1%29.4%22.3%21.5%24.0%19.2%18.9%18.2%-10.9%4.6%4.3%8.0%

Shareholding Pattern

Insiders
3.11%
Institutions
76.61%
Public Float
79.07%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 8.84% 4.29M $24.85M
2 Charles Schwab Investment Management, Inc. 4.41% 2.14M $12.41M
3 Vanguard Capital Management LLC 4.25% 2.06M $11.95M
4 American Century Companies Inc 4.16% 2.02M $11.70M
5 Prescott Group Capital Management, L.L.C. 3.70% 1.79M $10.39M
6 Acadian Asset Management. LLC 3.63% 1.76M $10.21M
7 Dimensional Fund Advisors LP 3.57% 1.74M $10.05M
8 Vanguard Portfolio Management LLC 3.52% 1.71M $9.90M
9 Renaissance Technologies, LLC 3.50% 1.70M $9.85M
10 AQR Capital Management, LLC 2.55% 1.24M $7.16M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NUS

No recent headlines available.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks